Search Results

There are 754267 results for: content related to: High-dose escitalopram in the treatment of binge-eating disorder with obesity: a placebo-controlled monotherapy trial

  1. Escitalopram versus other antidepressive agents for depression

    Intervention Review

    The Cochrane Library

    Andrea Cipriani, Claudio Santilli, Toshi A Furukawa, Alessandra Signoretti, Atsuo Nakagawa, Hugh McGuire, Rachel Churchill and Corrado Barbui

    Published Online : 15 APR 2009, DOI: 10.1002/14651858.CD006532.pub2

  2. Escitalopram in a working population: results from an observational study of 2378 outpatients in Austria

    Human Psychopharmacology: Clinical and Experimental

    Volume 22, Issue 4, June 2007, Pages: 245–251, Dietmar Winkler, Edda Pjrek, Ulrike Moser and Siegfried Kasper

    Version of Record online : 18 APR 2007, DOI: 10.1002/hup.839

  3. Pharmacokinetic modelling of blood–brain barrier transport of escitalopram in rats

    Biopharmaceutics & Drug Disposition

    Volume 28, Issue 7, October 2007, Pages: 349–360, Christoffer Bundgaard, Martin Jørgensen and Frank Larsen

    Version of Record online : 25 JUL 2007, DOI: 10.1002/bdd.562

  4. Impact of the Ultrarapid CYP2C19*17 Allele on Serum Concentration of Escitalopram in Psychiatric Patients

    Clinical Pharmacology & Therapeutics

    Volume 83, Issue 2, February 2008, Pages: 322–327, I Rudberg, B Mohebi, M Hermann, H Refsum and E Molden

    Version of Record online : 11 JUL 2007, DOI: 10.1038/sj.clpt.6100291

  5. You have free access to this content
    Blockade of the high-affinity noradrenaline transporter (NET) by the selective 5-HT reuptake inhibitor escitalopram: an in vivo microdialysis study in mice

    British Journal of Pharmacology

    Volume 168, Issue 1, January 2013, Pages: 103–116, Hai T Nguyen, Bruno P Guiard, Alexandre Bacq, Denis J David, Indira David, Gaël Quesseveur, Sophie Gautron, Connie Sanchez and Alain M Gardier

    Version of Record online : 18 DEC 2012, DOI: 10.1111/j.1476-5381.2012.01850.x

  6. You have full text access to this OnlineOpen article
    Escitalopram in the treatment of major depressive disorder: clinical efficacy, tolerability and cost-effectiveness vs. venlafaxine extended-release formulation

    International Journal of Clinical Practice

    Volume 61, Issue 4, April 2007, Pages: 702–710, P. M. Llorca and J.-L. Fernandez

    Version of Record online : 22 MAR 2007, DOI: 10.1111/j.1742-1241.2007.01335.x

  7. Randomized placebo-controlled trial of escitalopram and venlafaxine XR in the treatment of generalized anxiety disorder

    Depression and Anxiety

    Volume 25, Issue 10, October 2008, Pages: 854–861, Anjana Bose, Andrew Korotzer, Carl Gommoll and Dayong Li

    Version of Record online : 29 NOV 2007, DOI: 10.1002/da.20355

  8. The Pharmacokinetics of Escitalopram After Oral and Intravenous Administration of Single and Multiple Doses to Healthy Subjects

    The Journal of Clinical Pharmacology

    Volume 45, Issue 12, December 2005, Pages: 1400–1406, B. Søgaard, H. Mengel, N. Rao and F. Larsen

    Version of Record online : 8 MAR 2013, DOI: 10.1177/0091270005280860

  9. Escitalopram Is a Weak Inhibitor of the CYP2D6-Catalyzed O-Demethylation of (+)-Tramadol but Does Not Reduce the Hypoalgesic Effect in Experimental Pain

    Clinical Pharmacology & Therapeutics

    Volume 86, Issue 6, December 2009, Pages: 626–633, L Noehr-Jensen, S T Zwisler, F Larsen, S H Sindrup, P Damkier and K Brosen

    Version of Record online : 26 AUG 2009, DOI: 10.1038/clpt.2009.154

  10. You have free access to this content
    Population pharmacokinetics and pharmacodynamics of escitalopram in overdose and the effect of activated charcoal

    British Journal of Clinical Pharmacology

    Volume 73, Issue 3, March 2012, Pages: 402–410, Freek van Gorp, Stephen Duffull, L. Peter Hackett and Geoffrey K. Isbister

    Version of Record online : 13 FEB 2012, DOI: 10.1111/j.1365-2125.2011.04091.x

  11. You have free access to this content
    Escitalopram in major depressive disorder: a multicenter, randomized, double-blind, fixed-dose, parallel trial in a Chinese population

    Depression and Anxiety

    Volume 25, Issue 1, January 2008, Pages: 46–54, Pei-xian Mao, Yi-lang Tang, Feng Jiang, Liang Shu, Xiuling Gu, Ming Li, Mincai Qian, Cui Ma, Philip B. Mitchell and Zhuo-ji Cai

    Version of Record online : 5 DEC 2006, DOI: 10.1002/da.20222

  12. You have free access to this content
    Escitalopram in the treatment of anxiety symptoms associated with depression

    Depression and Anxiety

    Volume 24, Issue 1, 2007, Pages: 53–61, Borwin Bandelow, Henning F. Andersen and Ornah T. Dolberg

    Version of Record online : 25 AUG 2006, DOI: 10.1002/da.20141

  13. Escitalopram in the treatment of generalized anxiety disorder: Double-blind, placebo controlled, flexible-dose study

    Depression and Anxiety

    Volume 19, Issue 4, 2004, Pages: 234–240, Jonathan R.T. Davidson, Anjana Bose, Andrew Korotzer and Hongjie Zheng

    Version of Record online : 11 JUN 2004, DOI: 10.1002/da.10146

  14. Effect of Age, Weight, and CYP2C19 Genotype on Escitalopram Exposure

    The Journal of Clinical Pharmacology

    Volume 50, Issue 1, January 2010, Pages: 62–72, Ms Yuyan Jin, Dr Bruce G. Pollock, Dr Ellen Frank, Dr Giovanni B. Cassano, Dr Paola Rucci, Dr Daniel J. Müller, Dr James L. Kennedy, Dr Rocco Nicola Forgione, Ms Margaret Kirshner, Ms Gail Kepple, Dr Andrea Fagiolini, David J. Kupfer and Dr Robert R. Bies

    Version of Record online : 7 MAR 2013, DOI: 10.1177/0091270009337946

  15. The Role of the Two-Pore Domain Potassium Channel TREK-1 in the Therapeutic Effects of Escitalopram in a Rat Model of Poststroke Depression

    CNS Neuroscience & Therapeutics

    Volume 21, Issue 6, June 2015, Pages: 504–512, Dai-Hua Lin, Xiang-Rong Zhang, Dong-Qing Ye, Guang-Jun Xi, Jiao-Jie Hui, Shan-Shan Liu, Lin-Jiang Li and Zhi-Jun Zhang

    Version of Record online : 10 FEB 2015, DOI: 10.1111/cns.12384

  16. ORIGINAL RESEARCH—PSYCHOLOGY: Changes in Sexual Functioning Associated with Duloxetine, Escitalopram, and Placebo in the Treatment of Patients with Major Depressive Disorder

    The Journal of Sexual Medicine

    Volume 4, Issue 4i, July 2007, Pages: 917–929, Anita Clayton, Susan Kornstein, Apurva Prakash, Craig Mallinckrodt and Madelaine Wohlreich

    Version of Record online : 10 JUL 2007, DOI: 10.1111/j.1743-6109.2007.00520.x

  17. Effect of Vortioxetine vs. Escitalopram on Sexual Functioning in Adults with Well-Treated Major Depressive Disorder Experiencing SSRI-Induced Sexual Dysfunction

    The Journal of Sexual Medicine

    Volume 12, Issue 10, October 2015, Pages: 2036–2048, Paula L. Jacobsen, Atul R. Mahableshwarkar, Yinzhong Chen, Lambros Chrones and Anita H. Clayton

    Version of Record online : 31 AUG 2015, DOI: 10.1111/jsm.12980

  18. Predicting 6-week treatment response to escitalopram pharmacotherapy in late-life major depressive disorder

    International Journal of Geriatric Psychiatry

    Volume 22, Issue 11, November 2007, Pages: 1141–1146, Ramin Saghafi, Charlotte Brown, Meryl A. Butters, Jill Cyranowski, Mary Amanda Dew, Ellen Frank, Ariel Gildengers, Jordan F. Karp, Eric J. Lenze, Francis Lotrich, Lynn Martire, Sati Mazumdar, Mark D. Miller, Benoit H. Mulsant, Elizabeth Weber, Ellen Whyte, Jennifer Morse, Jacqueline Stack, Patricia R. Houck, Salem Bensasi and Charles F. Reynolds III

    Version of Record online : 8 MAY 2007, DOI: 10.1002/gps.1804

  19. Protein Kinases Alter the Allosteric Modulation of the Serotonin Transporter In Vivo and In Vitro

    CNS Neuroscience & Therapeutics

    Volume 22, Issue 8, August 2016, Pages: 691–699, Ouissame Mnie-Filali, Thorsten Lau, Friederike Matthaeus, Erika Abrial, Sarah Delcourte, Mostafa El Mansari, Alan Pershon, Patrick Schloss, Connie Sánchez and Nasser Haddjeri

    Version of Record online : 12 MAY 2016, DOI: 10.1111/cns.12562

  20. Female Sexual Dysfunction in Patients Treated with Antidepressant—Comparison between Escitalopram and Fluoxetine

    The Journal of Sexual Medicine

    Volume 9, Issue 5, May 2012, Pages: 1392–1399, Hatta Sidi, Duni Asmidar, Rozita Hod and Ng Chong Guan

    Version of Record online : 7 APR 2011, DOI: 10.1111/j.1743-6109.2011.02256.x